Our Portfolio

University of California, San Diego

Leon Thal, MD | California, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $399,891 Funding Amount
  • 8/6/99 — 9/14/04 Project Duration
  • Drug Discovery Program
  • zBiomarker/Diagnostic Validation - Clinical Therapeutic Stage
  • Closed Status

University of California, San Diego

Leon Thal, MD | California, United States

Utility of MRI to Predict Progression from MCI to AD and Treatment Response to Vitamin E and Donepezil

GET IN TOUCH